Cinctive Capital Management LP Purchases 187,432 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Cinctive Capital Management LP increased its holdings in Bath & Body Works, buying an additional 187,432 shares, resulting in a total of 361,218 shares, which constitutes 0.8% of its portfolio.
• The company reported a quarterly earnings per share (EPS) of $0.37, aligning with analyst expectations, although revenue decreased by 0.8% year-over-year.
• A quarterly dividend of $0.20 per share has been declared, representing an annual yield of 2.6%, with a payout ratio of 23.74%.

Cinctive Capital Management LP increased its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 107.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 361,218 shares of the company's stock after acquiring an additional 187,432 shares during the quarter. Bath & Body Works comprises approximately 0.8% of Cinctive Capital Management LP's portfolio, making the stock its 24th biggest position. Cinctive Capital Management LP owned 0.17% of Bath & Body Works worth $10,952,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Mercer Global Advisors Inc. ADV bought a new stake in shares of Bath & Body Works during the fourth quarter valued at approximately $2,910,000. Ancora Advisors LLC bought a new position in shares of Bath & Body Works in the 4th quarter worth about $67,000. BNP Paribas Financial Markets bought a new position in shares of Bath & Body Works during the fourth quarter valued at approximately $36,445,000. Bank of America Corp DE boosted its stake in Bath & Body Works by 50.4% in the 4th quarter. Bank of America Corp DE now owns 1,741,712 shares of the company's stock worth $67,526,000 after purchasing an additional 583,337 shares in the last quarter. Finally, Baird Financial Group Inc. purchased a new stake in shares of Bath & Body Works during the fourth quarter valued at $1,381,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

Shares of NYSE BBWI traded down $0.17 during midday trading on Tuesday, reaching $28.32. The stock had a trading volume of 2,828,570 shares, compared to its average volume of 5,286,184. The company has a market capitalization of $5.84 billion, a price-to-earnings ratio of 8.41, a price-to-earnings-growth ratio of 1.01 and a beta of 1.49. The stock has a 50-day moving average of $30.70 and a 200-day moving average of $30.38. Bath & Body Works, Inc. has a 12-month low of $24.94 and a 12-month high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.55 billion for the quarter, compared to analysts' expectations of $1.55 billion. During the same period in the previous year, the firm posted $0.37 earnings per share. The business's revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were given a dividend of $0.20 per share. The ex-dividend date was Friday, August 22nd. This represents a $0.80 annualized dividend and a yield of 2.8%. Bath & Body Works's dividend payout ratio (DPR) is 23.74%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on BBWI. Piper Sandler set a $39.00 price target on shares of Bath & Body Works and gave the company an "overweight" rating in a report on Thursday, May 15th. Telsey Advisory Group reissued an "outperform" rating and set a $38.00 price target on shares of Bath & Body Works in a report on Thursday, August 28th. Barclays upped their price objective on Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a research report on Friday, August 29th. Wall Street Zen downgraded Bath & Body Works from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a report on Monday, July 28th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $41.62.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.